Kurt A. Gustafson - 01 Nov 2022 Form 4 Insider Report for OmniAb Operations, Inc.

Role
EVP, Finance and CFO
Signature
/s/ Charles S. Berkman, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Nov 2022
Net transactions value
$0
Form type
4
Filing time
03 Nov 2022, 21:13:33 UTC
Previous filing
30 Sep 2022
Next filing
29 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction Common Stock Award $0 +17,792 $0.000000 17,792 01 Nov 2022 Direct F1
transaction Common Stock Disposed to Issuer -17,792 -100% 0 01 Nov 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction Stock Option Award $0 +71,174 $0.000000 71,174 01 Nov 2022 Common Stock 71,174 $60.68 Direct F3
transaction Stock Option Disposed to Issuer -71,174 -100% 0 01 Nov 2022 Common Stock 71,174 $60.68 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Kurt A. Gustafson is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Includes 14,234 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire.
F2 Pursuant to the business combination of Avista Public Acquisition Corp. II (after consummation of the transaction contemplated here, "New OmniAb") and the Issuer, as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of the Issuer will automatically convert into the right to receive securities of New OmniAb with the same terms and conditions in accordance with exchange ratios described in the Merger Agreement.
F3 The stock option vests and is exercisable as to 12.5% of the underlying shares on October 8, 2022, and in 42 substantially equal monthly installments thereafter.